CGHGX | RELVX | CGHGX / RELVX | |
Total Expense Ratio | 0.51 | 1.43 | 36% |
Annual Report Gross Expense Ratio | 0.56 | 1.67 | 34% |
Fund Existence | 5 years | 28 years | - |
Gain YTD | 19.637 | 15.287 | 128% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.06B | 319M | 2,212% |
Annual Yield % from dividends | 0.77 | 1.44 | 53% |
Returns for 1 year | 13.60 | 12.78 | 106% |
Returns for 3 years | 63.41 | 59.23 | 107% |
Returns for 5 years | N/A | 50.91 | - |
Returns for 10 years | N/A | 68.48 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MSTSX | 12.24 | 0.08 | +0.66% |
Morningstar Global Opportunistic Equity | |||
NBHAX | 15.14 | 0.01 | +0.07% |
Neuberger Berman Equity Income A | |||
BIPSX | 29.24 | -0.05 | -0.17% |
ProFunds Biotechnology UltraSector Svc | |||
GAHPX | 29.99 | -0.06 | -0.20% |
Goldman Sachs Emerging Markets Eq P | |||
MINHX | 45.75 | -0.30 | -0.65% |
MFS International Intrinsic Value R4 |